114 related articles for article (PubMed ID: 37886575)
1. New Insights into Macrophage Polarization and its Prognostic Role in Patients with Colorectal Cancer Liver Metastasis.
Khanduri I; Maki H; Verma A; Katkhuda R; Anandappa G; Pandurengan R; Zhang S; Mejia A; Tong Z; Soto LMS; Jadhav A; Wistuba II; Kopetz S; Parra ER; Vauthey JN; Maru DM
Res Sq; 2023 Oct; ():. PubMed ID: 37886575
[TBL] [Abstract][Full Text] [Related]
2. Exploratory study of macrophage polarization and spatial distribution in colorectal cancer liver metastasis: a pilot study.
Khanduri I; Maru DM; Parra ER
Front Immunol; 2023; 14():1223864. PubMed ID: 37637998
[TBL] [Abstract][Full Text] [Related]
3. Low Concordance Between T-Cell Densities in Matched Primary Tumors and Liver Metastases in Microsatellite Stable Colorectal Cancer.
Dagenborg VJ; Marshall SE; Grzyb K; Fretland ÅA; Lund-Iversen M; Mælandsmo GM; Ree AH; Edwin B; Yaqub S; Flatmark K
Front Oncol; 2021; 11():671629. PubMed ID: 34178659
[TBL] [Abstract][Full Text] [Related]
4. The impact of resection margin on overall survival for patients with colon cancer liver metastasis varied according to the primary cancer location.
McVey JC; Sasaki K; Margonis GA; Nowacki AS; Firl DJ; He J; Berber E; Wolfgang C; Miller CC; Weiss M; Aucejo FN
HPB (Oxford); 2019 Jun; 21(6):702-710. PubMed ID: 30501989
[TBL] [Abstract][Full Text] [Related]
5. Aggressive recurrences determine oncologic outcomes after resection of liver metastases from primary right colon cancer: Results of a case-control study.
Zimmitti G; Panettieri E; Ardito F; Mele C; Maria V; Rosso E; Nuzzo G; Giuliante F
Eur J Surg Oncol; 2021 Apr; 47(4):834-841. PubMed ID: 33032866
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Adjuvant Chemotherapy According to the Classification of Recurrence Risk Based on Systemic Inflammatory Markers in Patients With Liver Metastases of Colorectal Cancer.
Shibutani M; Nagahara H; Fukuoka T; Iseki Y; Hirakawa K; Ohira M
Anticancer Res; 2019 Sep; 39(9):5039-5045. PubMed ID: 31519612
[TBL] [Abstract][Full Text] [Related]
7. High Neutrophil-To-Lymphocyte Ratio (NLR) and Systemic Immune-Inflammation Index (SII) Are Markers of Longer Survival After Metastasectomy of Patients With Liver-Only Metastasis of Rectal Cancer.
Polk N; Budai B; Hitre E; Patócs A; Mersich T
Pathol Oncol Res; 2022; 28():1610315. PubMed ID: 35570841
[No Abstract] [Full Text] [Related]
8. Prognostic influence of hepatic margin after resection of colorectal liver metastasis: role of modern preoperative chemotherapy.
Makowiec F; Bronsert P; Klock A; Hopt UT; Neeff HP
Int J Colorectal Dis; 2018 Jan; 33(1):71-78. PubMed ID: 29098384
[TBL] [Abstract][Full Text] [Related]
9. The Prognostic Role of Macrophage Polarization in the Colorectal Cancer Microenvironment.
Väyrynen JP; Haruki K; Lau MC; Väyrynen SA; Zhong R; Dias Costa A; Borowsky J; Zhao M; Fujiyoshi K; Arima K; Twombly TS; Kishikawa J; Gu S; Aminmozaffari S; Shi S; Baba Y; Akimoto N; Ugai T; Da Silva A; Guerriero JL; Song M; Wu K; Chan AT; Nishihara R; Fuchs CS; Meyerhardt JA; Giannakis M; Ogino S; Nowak JA
Cancer Immunol Res; 2021 Jan; 9(1):8-19. PubMed ID: 33023967
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil-to-Lymphocyte Ratio and Intratumoral CD45RO-Positive T Cells as Predictive Factors for Longer Survival of Patients with Colorectal Liver Metastasis after Hepatectomy.
Hamada T; Ishizaki H; Haruyama Y; Hamada R; Yano K; Kondo K; Kataoka H; Nanashima A
Tohoku J Exp Med; 2020 Aug; 251(4):303-311. PubMed ID: 32779620
[TBL] [Abstract][Full Text] [Related]
11. Macelignan prevents colorectal cancer metastasis by inhibiting M2 macrophage polarization.
Che N; Li M; Liu X; Cui CA; Gong J; Xuan Y
Phytomedicine; 2024 Jan; 122():155144. PubMed ID: 37925889
[TBL] [Abstract][Full Text] [Related]
12. Intrahepatic CD69
Bruni E; Cimino MM; Donadon M; Carriero R; Terzoli S; Piazza R; Ravens S; Prinz I; Cazzetta V; Marzano P; Kunderfranco P; Peano C; Soldani C; Franceschini B; Colombo FS; Garlanda C; Mantovani A; Torzilli G; Mikulak J; Mavilio D
J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35863820
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value and clinicopathological roles of phenotypes of tumour-associated macrophages in colorectal cancer.
Zhao Y; Ge X; Xu X; Yu S; Wang J; Sun L
J Cancer Res Clin Oncol; 2019 Dec; 145(12):3005-3019. PubMed ID: 31650222
[TBL] [Abstract][Full Text] [Related]
14. High-Resolution Analysis of Mononuclear Phagocytes Reveals GPNMB as a Prognostic Marker in Human Colorectal Liver Metastasis.
Cortese N; Carriero R; Barbagallo M; Putignano AR; Costa G; Giavazzi F; Grizzi F; Pasqualini F; Peano C; Basso G; Marchini S; Colombo FS; Soldani C; Franceschini B; Di Tommaso L; Terracciano L; Donadon M; Torzilli G; Kunderfranco P; Mantovani A; Marchesi F
Cancer Immunol Res; 2023 Apr; 11(4):405-420. PubMed ID: 36652202
[TBL] [Abstract][Full Text] [Related]
15. A New Surveillance Algorithm After Resection of Colorectal Liver Metastases Based on Changes in Recurrence Risk and RAS Mutation Status.
Kawaguchi Y; Kopetz S; Lillemoe HA; Hwang H; Wang X; Tzeng CD; Chun YS; Aloia TA; Vauthey JN
J Natl Compr Canc Netw; 2020 Nov; 18(11):1500-1508. PubMed ID: 33152698
[TBL] [Abstract][Full Text] [Related]
16. Embryonic origin of primary colon cancer predicts survival in patients undergoing ablation for colorectal liver metastases.
Yamashita S; Odisio BC; Huang SY; Kopetz SE; Ahrar K; Chun YS; Conrad C; Aloia TA; Gupta S; Harmoush S; Hicks ME; Vauthey JN
Eur J Surg Oncol; 2017 Jun; 43(6):1040-1049. PubMed ID: 28187878
[TBL] [Abstract][Full Text] [Related]
17. Astragalus mongholicus Bunge-Curcuma aromatica Salisb. suppresses growth and metastasis of colorectal cancer cells by inhibiting M2 macrophage polarization via a Sp1/ZFAS1/miR-153-3p/CCR5 regulatory axis.
Gu J; Sun R; Tang D; Liu F; Chang X; Wang Q
Cell Biol Toxicol; 2022 Aug; 38(4):679-697. PubMed ID: 35072892
[TBL] [Abstract][Full Text] [Related]
18. Early liver metastases after "failure" of adjuvant chemotherapy for stage III colorectal cancer: is there a role for additional adjuvant therapy?
Boerner T; Zambirinis C; Gagnière J; Chou JF; Gonen M; Kemeny NE; Cercek A; Connell LC; Kingham TP; Allen PJ; Balachandran VP; Drebin J; Jarnagin WR; D'Angelica MI
HPB (Oxford); 2021 Apr; 23(4):601-608. PubMed ID: 32943326
[TBL] [Abstract][Full Text] [Related]
19. Effect of Adding Bevacizumab to Chemotherapy on Pathologic Response to Preoperative Systemic Therapy for Resectable Colorectal Liver Metastases: A Systematic Review and Meta-analysis.
Jácome AA; Oliveira FA; Lino F; Lima JPSN
Clin Colorectal Cancer; 2021 Sep; 20(3):265-272. PubMed ID: 34158251
[TBL] [Abstract][Full Text] [Related]
20. Defining the surgical management for non-colorectal liver metastases.
Luk Y; She WH; Tsang SHY; Dai WC; Chan ACY; Cheung TT; Lo CM
Langenbecks Arch Surg; 2023 Jan; 408(1):35. PubMed ID: 36648566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
